Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
Open accessThe DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Abstract
Quinolinic acid (QUIN), a neuroactive metabolite of the kynurenine pathway, is normally presented in nanomolar concentrations in human brain and cerebrospinal fluid (CSF) and is often implicated in the pathogenesis of a variety of human neurological diseases. QUIN is an agonist of N-methyl-D-aspartate (NMDA) receptor, and it has a high in vivo potency as an excitotoxin. In fact, although QUIN has an uptake system, its neuronal degradation enzyme is rapidly saturated, and the rest of extracellular QUIN can continue stimulating the NMDA receptor. However, its toxicity cannot be fully explained by its activation of NMDA receptors it is likely that additional mechanisms may also be involved. In this review we describe some of the most relevant targets of QUIN neurotoxicity which involves presynaptic receptors, energetic dysfunction, oxidative stress, transcription factors, cytoskeletal disruption, behavior alterations, and cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, QUIN increases the release and blocks the reuptake of glutamate in astrocytes, thus increasing glutamatergic extracellular concentrations (132).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [132]
In the citing paper
“Together, this pathway may trigger hippocampal and mPFC cellular damage and volume reductions (138,144,145).”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543 · cited 1×
“Areas of the brain most sensitive to QUIN neurotoxicity are the hippocampus and striatum [32] in which the NMDA receptors are widely distributed [33].”
BackgroundReplication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242 · cited 1×
“Although TNF-α is not neurotoxic itself, this proinflammatory cytokine can contribute to neuronal damage through a variety of effects, such as stimulation of free radical formation, induction of cellular adhesion molecule expression, or potentiation of glutamatemediate neurotoxicity [123, 124].”
BackgroundNeuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948 · cited 3×
“Furthermore, 3-HAO activity may normally be restrained by factors such as the availability of Fe ions [8, 22, 23].”
BackgroundSchulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., & Fiers, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42768-8 · Cited by 939
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751 · cited 2×
“In 1981, Stone and Perkins discovered that QUIN was a potent excitant of neurons in the CNS, by acting as an agonist at the N-methyl-D-aspartate (NMDA) sensitive population glutamate receptors [29], and Schwarcz and coworkers (1983) were the first who demonstrated that QUIN causes selective neuronal lesions, and they…”
BackgroundKynurenine Pathway Metabolites in Humans: Disease and Healthy States
Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 628 · cited 1×
“8 nmol/g wet weight; almost 2-fold than that found in the hippocampus (1 nmol/g wet weight) [16–18].”
BackgroundSteiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 3×
“As shown previously in cortical neurons, dopaminergic neurons do not produce QUIN but take it up from the microenvironment [15, 40].”
Background
Research works printed but not linked: 1
- Blanco-Ayala T Serratos-Alvarez I Orozco-Ibarra M Effect of some kynurenines under succinate deshidrogenase activity and ATP production: in vitro experimental and computational tools Neuroscience Meeting 2012 60.09 New Orleans, LA, USA Society for Neuroscience
Cited by
Items 201–300 of 426
Sandvig, H. V., Aam, S., Alme, K. N., Lydersen, S., Ueland, P. M., Ulvik, A., Wethal, T., Saltvedt, I. T., & Knapskog, A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.030 · Cited by 19
“In the brain following stroke, QA is produced by activated microglia and by infiltrating macrophages (Lugo-Huitr ´ on et al., 2013; Moffett et al., 2020), while hepatocytes and peripheral immune cells contribute to plasma QA (Moffett et al., 2020).”
BackgroundInfluentialThe Neurochemistry of Depression: The Good, The Bad and The Ugly.
Pearson, K., Beier, K., Mardis, T., Munoz, B., & Zaidi, A. (2024) · PubMed Central · Cited by 26
Formisano, S., Hornig, M., Yaddanapudi, K., Vasishtha, M., Parsons, L. H., Briese, T., Lipkin, W. I., & Williams, B. L. (2017) · Journal of Virology · doi:10.1128/jvi.00673-17 · Cited by 17
Santisukwongchote, K., Amornlertwatana, Y., Sastraruji, T., & Jaikang, C. (2019) · Metabolites · doi:10.3390/metabo10010006 · Cited by 17
“This process was an oxidative stress defense mechanism which decreased pro-oxidant QA level and increased antioxidant PA molecules [23,24].”
BackgroundMandal, G., Kirkpatrick, M., Alboni, S., Mariani, N., Pariante, C. M., & Borsini, A. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae041 · Cited by 15
“In addition to its role in NAD+ production, QUIN also behaves as an NMDA receptor agonist, inducing neurotoxicity via glutamate excitotoxicity and ultimately resulting in reduced hippocampal neurogenesis (Lugo-Huitrón et al., 2013).”
Huang, M., Singh, N., Kainth, R., Khalid, M., Kushwah, A. S., & Kumar, M. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8584558 · Cited by 18
“Receptors like Nmethyl D-aspartate (NMDARs) are an essential component of long-lasting potentiation and depression, and calciuminflux via NMDARs and voltage-gated calcium (Ca2+) channels (VGCCs) strengthens the synapse.”
BackgroundInfluentialThe Janus-Faced Nature of Ido1 in Infectious Diseases: Challenges and Therapeutic Opportunities
Greco, F. A., Coletti, A., Camaioni, E., Carotti, A., Marinozzi, M., Gioiello, A., & Macchiarulo, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.165 · Cited by 15
The role of NAD metabolism in neuronal differentiation
Neves, D., Goodfellow, B. J., Vieira, S. I., & Silva, R. M. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105402 · Cited by 16
de Bartolomeis, A., Fornaro, M., Scopetta, E., Ricci, C., Irano, A., Simone, G. D., Comai, S., Iasevoli, F., & Caiazza, C. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.10.005 · Cited by 14
Optical Spectroscopy of Tryptophan Metabolites in Neurodegenerative Disease
Sordillo, L. A., & Sordillo, P. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-48067-3.00007-x · Cited by 17
Kupjetz, M., Chirino, T. Y. W., Joisten, N., & Zimmer, P. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149415 · Cited by 16
Amaral, A. U., Seminotti, B., da Silva, J. C., de Oliveira, F. H., Ribeiro, R. T., Vargas, C. R., Leipnitz, G., Santamaría, A., Souza, D. O., & Wajner, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9848-0 · Cited by 14
Tomczyk, M., Bidzan-Wiącek, M., Kortas, J. A., Kochanowicz, M., Jost, Z., Fisk, H. L., Calder, P. C., & Antosiewicz, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-54112-x · Cited by 14
“Our results suggest that n-3 PUFA supplementation accompanied by endurance training leads to increased formation of neuroprotective PA but not QA, which exhibits well established neurotoxic properties 32 .”
ResultHuman serine racemase is allosterically modulated by NADH and reduced nicotinamide derivatives
Bruno, S., Marchesani, F., Dellafiora, L., Margiotta, M., Faggiano, S., Campanini, B., & Mozzarelli, A. (2016) · Biochemical Journal · doi:10.1042/bcj20160566 · Cited by 17
Neuronal Proteins as Targets of 3-Hydroxykynurenine: Implications in Neurodegenerative Diseases
Capucciati, A., Galliano, M., Bubacco, L., Zecca, L., Casella, L., Monzani, E., & Nicolis, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00265 · Cited by 14
Gelpi, M., Vestad, B., Raju, S. C., Hansen, S. H., Høgh, J., Midttun, Ø., Ueland, P. M., Ueland, T., Benfield, T., Kofoed, K. F., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac018 · Cited by 16
Ferreira, F. S., dos Santos, T. M., Júnior, O. V. R., Silveira, J. S., Schmitz, F., & Wyse, Â. T. D. S. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00484-9 · Cited by 13
“Studies show that QUIN causes many neurotoxic effects in the CNS, being the production of reactive species, the alteration of the mitochondrial function, and the inflammatory process considered important mechanisms of action of this metabolite (Lugo-Huitrón et al. 2013).”
BackgroundBettini, E., Martin, S. D., Mattarei, A., Pappagallo, M., Stahl, S. M., Bifari, F., Inturrisi, C. E., Folli, F. B., Traversa, S., & Manfredi, P. L. (2022) · Pharmaceuticals · doi:10.3390/ph15070882 · Cited by 13
“Accumulation of endogenous QA has been implicated in the etiology of neurological diseases [10,11] and psychiatric disorders, including depression [12–19].”
BackgroundAlachkar, A. (2022) · Physics of Life Reviews · doi:10.1016/j.plrev.2022.07.002 · Cited by 13
Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy
Ueland, H. O., Ulvik, A., Løvås, K., Wolff, A. S. B., Breivik, L. H., Stokland, A. M., Rødahl, E., Nilsen, R. M., Husebye, E. S., & Ueland, G. Å. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad004 · Cited by 15
“High QA has earlier been found in relation to multiple neurologic diseases (37), but QA and the QA/Pic ratio has not been studied in GD.”
ResultDehhaghi, M., Tan, V. X., Heng, B., Braidy, N., Mohammadipanah, F., & Guillemin, G. J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9945-8 · Cited by 14
Savino, R., Carotenuto, M., Polito, A. N., Di Noia, S., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N., & Messina, G. (2020) · doi:10.20944/preprints202007.0425.v1 · Cited by 54
Boban, A., Vrhovšek, U., Anesi, A., Milanović, V., Kljusurić, J. G., Jurun, Z., & Budić-Leto, I. (2024) · Foods · doi:10.3390/foods13182939 · Cited by 12
“OH-ANT can further convert into other compounds, such as quinolinic acid, and has antioxidant properties that positively impact health [32].”
BackgroundJørgensen, S. F., Braadland, P. R., Ueland, T., Fraz, M. S. A., Michelsen, A. E., Holm, K., Osnes, L., Trøseid, M., Ueland, P. M., Fevang, B., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.04.031 · Cited by 12
O’Regan, G., Plummer, Z., Christie, B. R., Shultz, S. R., & Allen, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03717-2 · Cited by 15
“Preclinical studies demonstrate that QA disrupts mitochondrial ATP production following intrastriatal administration, although it remains unclear whether this arises from direct mitochondrial toxicity or occurs secondary to ROS generation following NMDAR overstimulation [140, 141].”
O’Reilly, K., O’Farrell, K., Midttun, Ø., Rakovets, Y., David‐Bercholz, J., & Harkin, A. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09976-x · Cited by 13
Daniyan, M. O., Fisusi, F. A., & Adeoye, B. O. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.965569 · Cited by 15
“leads to the generation of quinolinic acid, a potent agonist of N-methyl-D-aspartate (NMDA) glutamate receptor (Guillemin et al., 2005; Lugo-Huitrón et al., 2013).”
BackgroundGenetic variations related to inflammation in suicidal ideation and behavior: A systematic review
Tamimou, R., Lumbroso, S., Mouzat, K., & López‐Castromán, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1003034 · Cited by 12
Altered Tryptophan-Kynurenine Pathway in Delirium: A Review of the Current Literature
Ang, H. P., Makpol, S., Nasaruddin, M. L., Zaidi, W. A. W., Ahmad, N. S., & Embong, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065580 · Cited by 15
Hetherington‐Rauth, M., Johnson, E. M., Migliavacca, E., Langsetmo, L., Hepple, R. T., RYAN, T. E., Ferrucci, L., Breuillé, D., Corthésy, J., Lane, N. E., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae131 · Cited by 12
New Perspective on Anorexia Nervosa: Tryptophan-Kynurenine Pathway Hypothesis
Alberts, C., Owe-Larsson, M., & Urbańska, E. M. (2023) · Nutrients · doi:10.3390/nu15041030 · Cited by 13
Contella, L., Farrell, C. L., Boccuto, L., Litwin, A. H., & Snyder, M. L. (2024) · Metabolites · doi:10.3390/metabo14110611 · Cited by 11
Inhaled pollutants and neurological health via the lung-brain axis
Li, H., Bian, H., Yuan, X., & Xu, Q. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119091 · Cited by 11
McGarry, A. J., Hunter, K. M., Gaughan, J., Auinger, P., Ferraro, T. N., Pradhan, B., Ferrucci, L., Egan, J. M., & Moaddel, R. (2024) · Scientific Reports · doi:10.1038/s41598-023-50553-y · Cited by 11
Osuch, B., Misztal, T., Pałatyńska, K., & Tomaszewska-Zaremba, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094845 · Cited by 11
“Inhibitors of these enzymes have been shown to normalize EtOH-induced changes at biochemical, molecular, and behavioral levels.”
Chauhan, R., Mohan, M., Mannan, A., Devi, S., & Singh, T. G. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114654 · Cited by 10
Myint, K., Jacobs, K. R., Myint, A.-M., Lam, S. K., Lim, Y. A. L., Boey, C. C. M., Hoe, S.-Z., & Guillemin, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702301 · Cited by 11
“3-HAA is also the main precursor for biosynthesis of the excitotoxin QUIN (67).”
ResultInfluentialMezo‐González, C. E., Abdi, A. D., Reyes‐Castro, L. A., Olvera-Hernández, S., Almeida, C., Croyal, M., Aguesse, A., Gavioli, E. C., Zambrano, E., & Bolaños, F. J. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221111116 · Cited by 11
Ottria, R., Xynomilakis, O., Casati, S., & Ciuffreda, P. (2024) · Microorganisms · doi:10.3390/microorganisms12081582 · Cited by 10
Ciapała, K., Pawlik, K., Ciechanowska, A., Mika, J., & Rojewska, E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116382 · Cited by 10
The kynurenine pathway in traumatic brain injuries and concussion
Dehhaghi, M., Heng, B., & Guillemin, G. J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1210453 · Cited by 10
“Moreover, QUIN can increase glutamate release from the neuron and inhibits glutamate uptake by astrocytes resulting in glutamate accumulation, neurotoxicity, and cell death (41, 45, 46) (Figure 2).”
BackgroundQuinolinic acid induces cell apoptosis in PC12 cells through HIF-1-dependent RTP801 activation
Huang, X., Yang, K., Zhang, Y., Wang, Q., & Li, Y. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-015-9782-x · Cited by 12
Preliminary Study of Probiotics and Kynurenine Pathway in Autism Spectrum Disorder
Tharawadeephimuk, W., Chaiyasut, C., Sirilun, S., & Sittiprapaporn, P. (2019) · International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON) · doi:10.1109/ecti-con47248.2019.8955380 · Cited by 11
Ruiz-Pablos, M., Paiva, B., & Zabaleta, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422940 · Cited by 9
“Furthermore, both astrocytes and neurons can use microglia-derived quinolinic acid as an alternative source to replenish NAD stores (206, 207).”
BackgroundKynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment
Carrillo‐Mora, P., Landa‐Solís, C., Valle‐García, D., Luna‐Angulo, A. B., Avilés‐Arnaut, H., Robles-Bañuelos, B., Sánchez‐Chapul, L., & Rangel‐López, E. (2024) · Pharmaceuticals · doi:10.3390/ph17080983 · Cited by 10
Understanding and treating postpartum depression: a narrative review
Cardaci, V., Carminati, M., Tondello, M., Pecorino, B., Serretti, A., & Zanardi, R. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000560 · Cited by 9
Leszczyńska, A., Misztal, T., Marcińczyk, N., Kaminski, T. W., Kramkowski, K., Chabielska, E., & Pawlak, D. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.05.003 · Cited by 9
Beaurain, M., Talmont, F., Pierre, D., Péran, P., Boucher, S., Hitzel, A., Rols, M., Cuvillier, O., Payoux, P., & Salabert, A. (2023) · Molecular Imaging and Biology · doi:10.1007/s11307-023-01811-y · Cited by 9
Gliozzi, M., Coppoletta, A. R., Cardamone, A., Musolino, V., Carresi, C., Nucera, S., Ruga, S., Scarano, F., Bosco, F., Guarnieri, L., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107087 · Cited by 9
Khiroya, K., Sekyere, E. O., McEwen, B. J., & Bayes, J. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000276 · Cited by 12
“Further, urine levels of quinolinic acid are not a reflection of its levels in the brain (68) .”
Secondary metabolites in Cordyceps javanica with insecticidal potential
Xing, P., Mao, R., Zhang, G., Li, Y., Zhou, W., Diao, H., & Ma, R. (2024) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2024.106076 · Cited by 9
Gene expression of kynurenine pathway enzymes in depression and following electroconvulsive therapy
Ryan, K. M., Corrigan, M., Murphy, T. M., McLoughlin, D. M., & Harkin, A. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.34 · Cited by 9
The aryl hydrocarbon receptor: A promising target for intestinal fibrosis therapy
Pan, Y., Deng, Y., Yang, H., & Yu, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107909 · Cited by 11
Cheng, S., Li, J., Chen, D. T.-L., Chien, Y.-C., Chang, J. P., Huang, S., Gałecki, P., & Su, K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030192 · Cited by 9
“After KYN is formed, it is metabolized into neurotoxic QUIN in the central nervous system [36], and QUIN may affect N-methyl-D-aspartate receptors [37] and glutamate regulations by astrocytes [38,39], resulting in an overstimulation of the glutamatergic system, neuronal structural changes, and even excitotoxicity [40].”
BackgroundZhao, L., Zhang, F., Wang, K., Zhang, X., Hu, G., Chen, E., Qiu, J., Yuan, C., & He, J. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114421 · Cited by 8
Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review
Lorkiewicz, P., & Waszkiewicz, N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206060 · Cited by 9
Александровна, П. В., Sysoev, Y. I., Gerasimova, E., & Okovityi, S. V. (2022) · Biomedicines · doi:10.3390/biomedicines10112783 · Cited by 9
“Additionally, to investigate the role of NMDAR in the modulation of locomotion and anxiety-like behavior in zebrafish, Experiment 8 was conducted using quinolinic acid (Sigma-Aldrich, USA), a potent NMDAR agonist [33,34], at a concentration range according to the same design (Figure 1A).”
MethodHilsabeck, T. A. U., Narayan, V. P., Wilson, K. A., Carrera, E. M., Raftery, D., Promislow, D., Brem, R. B., Campisi, J., & Kapahi, P. (2024) · Nature Communications · doi:10.1038/s41467-024-52909-y · Cited by 7
Serretti, A., Fabbri, C., Fanelli, G., Baune, B. T., Minelli, A., Serretti, A., Dierssen, M., Maron, E., Potier, M.-C., Gennarelli, M., et al. (2025) · Neuroscience Applied · doi:10.1016/j.nsa.2025.105530 · Cited by 9
“…blood brain barrier (BBB) leakiness, permits peripheral cytokines to diffuse into the parenchyma, activating microglia and shifting tryptophan metabolism toward quinolinic-acid neurotoxicity (Marlevi and Edelman, 2021; da Fonseca et al., 2014; Lugo-Huitr ´ on et al., 2013; Mithaiwala et al., 2021).”
Li, G., Li, S., & Zhou, W. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1617690 · Cited by 8
Cell Signaling by Tryptophan Catabolism
Torrelli-Diljohn, A., Kulkarni, B., & Vitturi, D. A. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00179 · Cited by 7
Systemic implications of osteoarthritis: from local degeneration to systemic metabolic Dysregulation
Luo, J., Li, L., Deng, Q., Ji, Z., Wang, C., & Dai, B. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08277-w · Cited by 9
“QUIN is a potent NMDA receptor agonist with strong neurotoxicity, capable of damaging hippocampal and cortical neurons [160].”
COVID-19. Biology, pathophysiology, and immunology: a pathologist view
Chilosi, M., Doglioni, C., Ravaglia, C., Piciucchi, S., Dubini, A., Stefanizzi, L., & Poletti, V. E. (2023) · Pathologica · doi:10.32074/1591-951x-954 · Cited by 7
Gusdon, A. M., Savarraj, J. P. J., Feng, D., STARKMAN, A. E., Li, G., Bodanapally, U. K., Zimmerman, W., Ryan, A. S., Choi, H. A., & Badjatia, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-64666-5 · Cited by 7
“Although we measured circulating quinolinate in plasma, quinolinate is also well known to have neurotoxic effects in the CNS as it is an agonist of the N-methyl-D-aspartate (NMDA) receptor and acts as an excitotoxin 47 .”
BackgroundContextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized Psychiatry
Murata, S., Oxenkrug, G. F., & Halaris, A. E. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16020118 · Cited by 6
Kupjetz, M., Langeskov‐Christensen, M., Riemenschneider, M., Inerle, S., Ligges, U., Gaemelke, T., Patt, N., Bansi, J., Gonzenbach, R. R., Reuter, M., et al. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200461 · Cited by 6
Fukngoen, P., Sivamaruthi, B. S., Sirilun, S., Lalitsuradej, E., Khongtan, S., Peerajan, S., Sittiprapaporn, P., & Chaiyasut, C. (2022) · Applied Sciences · doi:10.3390/app12115658 · Cited by 7
Deng, S., Zhang, E., Zhao, Y., Guo, H., Luo, L. E., Yi, S., Zheng, B., Mu, X., Yuan, K., Deng, X., et al. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109865 · Cited by 6
Visualization of incrementally learned projection trajectories for longitudinal data
Malepathirana, T., Senanayake, D., Gautam, V., Engel, M., Balez, R., Lovelace, M. D., Sundaram, G., Heng, B., Chow, S., Marquis, C. P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63511-z · Cited by 6
“QUIN excitotoxicity and metabolism are very much associated with 273 the aging process[25, 26], thus the long-term effect of QUIN Ab on QUIN 274 should be studied.”
BackgroundHaam, J.-H., Lee, Y. K., Suh, E., Choi, S., Chun, H., & Kim, Y. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0598 · Cited by 6
Basson, C., Serem, J. C., Bipath, P., & Hlophe, Y. N. (2024) · Cell Biology International · doi:10.1002/cbin.12163 · Cited by 6
“Previous evidence indicated that Quin induced striatal neuron death, through both apoptotic and autophagic mechanisms, induced by nuclear factor kappa B and p53 (Lugo ‐ Huitrón et al., 2013).”
BackgroundO’Connell, A. B., Kuchel, T. R., Perumal, S. R., Sherwood, V., Neumann, D., Finnie, J. W., Hemsley, K. M., & Morton, A. J. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa053 · Cited by 6
Rani, S., Yadav, S., & Ghorai, S. M. (2023) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822262191231024081805 · Cited by 5
Tryptophan pathway profiling in multiple sclerosis patients treated with ocrelizumab
Ricci, C., Pivetta, M., Martinis, E., Valeri, V., Colliva, C., Giacchè, N., Lorenzut, S., Cargnelutti, D., Frossi, B., & Tonon, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603663 · Cited by 5
“Higher QA concentrations have been observed during CNS in fl ammation (29) and it has been proved that QA is neurotoxic (30).”
Chojnacki, M., Błońska, A., Kaczka, A., Chojnacki, J., Walecka‐Kapica, E., Romanowska, N., Przybyłowska-Sygut, K., & Popławski, T. (2025) · Nutrients · doi:10.3390/nu17132232 · Cited by 6
“Previously, increased levels of quinolinic acid have been found in irritable bowel syndrome [59], as well as in chronic fatigue [60].”
Losing the Filter: How Kynurenine Pathway Dysregulation Impairs Habituation
de la Flor, M. A., & O’Connor, J. C. (2025) · Cells · doi:10.3390/cells14221786 · Cited by 5
Turcatel, G. A., & Moura, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c05841 · Cited by 6
Wal, P., Dutta, A., Jawaid, T., Rahman, M. U., Gowri, K., Jyothi, S. R., Kaur, I., Al-Hasnaawei, S., Sinha, A., Maharana, L., et al. (2026) · Biogerontology · doi:10.1007/s10522-026-10394-4 · Cited by 7
Gut–Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia
Katiraei, P., Frye, R. E., & Theoharides, T. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041768 · Cited by 5
“Microglia can also alter the levels of quinolinic acid [215], a potent neurotoxin implicated in ASD [216].”
Sharma, A., & Singh, T. G. (2026) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2026.104097 · Cited by 7
Jackson, P. P. J., Wijeyesekera, A., & Rastall, R. A. (2023) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiad100 · Cited by 6
Gholipour-Kanani, H., Punithan, V. G., Severn‐Ellis, A. A., Clarke, M. W., & Dang, C. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741242 · Cited by 5
Thimmapuram, J., Patel, K. D., Bhatt, D., Chauhan, A., Madhusudhan, D. K., Bhatt, K. K., Deshpande, S., Budhbhatti, U., & Joshi, C. G. (2024) · JMIR Bioinformatics and Biotechnology · doi:10.2196/65506 · Cited by 6
Recent advances on the role of pro-inflammatory cytokine interleukin-18 in post-stroke depression
Zhang, Y., Li, H., Li, Z., Yang, S., Niu, D., Yang, Y., & Xu, X. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100037 · Cited by 7
Elraey, S. G. E., Shebl, M. M., Kholy, R. M. E., & Barhoma, R. A. (2021) · Tanta Medical Journal · doi:10.4103/tmj.tmj_50_19 · Cited by 5
Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Algon, A. A. A., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · Research Square · doi:10.21203/rs.3.rs-1408493/v1 · Cited by 5
Ortega, D. R., Pérez, E. R. H., Magdaleno, M. G., Meza‐Sosa, K. F., Calderas, L. P., Silva, M. J. A., Cervantes, G. I. V., González‐Esquivel, D. F., González-Alfonso, W. L., Cossio, J. Á. N., et al. (2026) · Nutrients · doi:10.3390/nu18010152 · Cited by 4
“In this model, mitochondrial dysfunction, calcium overload, ROS production, and eventual neuronal death occur [57].”
Self-citationHills, C., Hernandez, C. A., Gabbay, V., & Berman, J. W. (2026) · Cells · doi:10.3390/cells15050399 · Cited by 4
“Overall, more research is needed to examine the interplay of peripheral inflammation, BBB disruption, neuronal damage, and depression specifically in virally suppressed PWH. Future work should also examine whether specific neurons are implicated in HIV-associated depression pathogenesis.”
Wang, Y., Chen, Y., Li, H., Sang, J., Chen, C., Xu, L., Zhang, W., Xiong, B., Jiang, R., Ren, X., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01823-x · Cited by 4
The possible role of quinolinic acid as a predictive marker in patients with SARS-CoV-2
Michaelis, S., Zelzer, S., Schneider, C. M., Schnedl, W. J., Baranyi, A., Meinitzer, A., Herrmann, M., & Enko, D. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117583 · Cited by 4
Codevelopment of gut microbial metabolism and visual neural circuitry over human infancy
Bonham, K. S., Margolis, E. T., Bottino, G. F., Sobrino, A. C., Patel, F., McCann, S., Zieff, M. R., Miles, M., Herr, D., Davel, L., et al. (2025) · mBio · doi:10.1128/mbio.00835-25 · Cited by 4
“Although quinolinic acid is part of the kynurenine pathway and is a neurotoxin that can cause neuronal dysfunction, it may also play a role in glutamate uptake in the brain (68, 69).”
Lyme Disease: A Zoonosis Tick-Borne Borrelia Bacterium [3/4]
Moumaris, M. (2023) · International Journal of Zoology and Animal Biology · doi:10.23880/izab-16000500 · Cited by 4
Physiological evaluation of PVP-coated AgNP in the rat small intestine: an ex vivo approach
Chávez-Hernández, J. A., España‐Sánchez, B. L., Aguirre-Bañuelos, P., Granados-López, L., Velarde‐Salcedo, A. J., Luna‐Bárcenas, G., & González, C. (2024) · Frontiers in Nanotechnology · doi:10.3389/fnano.2024.1386312 · Cited by 4
Neurodevelopmental and Neuropsychiatric Disorders
Traetta, M. E., Filho, A. M. C., Akinluyi, E. T., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_26 · Cited by 4
Metabolic control of microglia in health and disease
Colombo, G., Monsorno, K., & Paolicelli, R. C. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19104-6.00009-7 · Cited by 4
Beasley, V. E., & Dowse, H. B. (2016) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.2057 · Cited by 4
Role of Kynurenine Pathway in Glioblastoma
Cervantes, G. I. V., Olascoaga, N. K., Ortega, D. R., Salazar, A., González‐Esquivel, D. F., Ríos, C., Pineda, B., & de la Cruz, V. P. (2017) · InTech eBooks · doi:10.5772/intechopen.68939 · Cited by 4
Self-citationFarup, P. G., & Hestad, K. A. (2022) · Applied Sciences · doi:10.3390/app12052648 · Cited by 4
“After surgery, the reduced KA/Kyn and KA/QA ratios could indicate reduced exercise and reduced neuroprotection, respectively, which did not fit the improved physical activity and mental health [1,3,13,14].”
BackgroundArtemisia Absinthium Extract Attenuates the Quinolinic Acid-Induced Cell Injury in OLN-93 Cells
Rashidi, R., Akaberi, M., Gholoobi, A., Ghazavi, H., & Forouzanfar, F. (2023) · Current Drug Discovery Technologies · doi:10.2174/1570163820666230330105331 · Cited by 4
Intermediate Filaments as a Target of Signaling Mechanisms in Neurotoxicity
Zamoner, A., & Pessoa‐Pureur, R. (2017) · InTech eBooks · doi:10.5772/66926 · Cited by 5
“The neurotoxicity of QUIN results from complex mechanisms including presynaptic receptors, energetic dysfunction, oxidative stress, transcription factors and behavior [33].”
Metadata
- Authors
- Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V.
- Affiliations
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Laboratorio de Neuroinmunología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-14
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC3780648
- OpenAlex
- W1991576487
- Cited by
- 394
- References
- 146
- Citations by year
- 2026: 44 · 2025: 48 · 2024: 50 · 2023: 41 · 2022: 54 · 2021: 42 · 2020: 23 · 2019: 17 · 2018: 16 · 2017: 23 · 2016: 21 · 2015: 11 · 2014: 4
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Consejo Nacional de Ciencia y Tecnología (183867)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- quinolinic acid, kynurenine pathway, neurotoxicity, excitotoxicity, presynaptic receptors, oxidative stress, transcription factors, cytoskeleton disruption, behavioral alterations, neuronal cell death, neurological disorders
- MeSH terms
- Animals, Energy Metabolism, Humans, Inflammation, Neurotoxins, Quinolinic Acid, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.